The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways

The EMBO Journal
J J VoegelH Gronemeyer

Abstract

The nuclear receptor (NR) coactivator TIF2 possesses a single NR interaction domain (NID) and two autonomous activation domains, AD1 and AD2. The TIF2 NID is composed of three NR-interacting modules each containing the NR box motif LxxLL. Mutation of boxes I, II and III abrogates TIF2-NR interaction and stimulation, in transfected cells, of the ligand-induced activation function-2 (AF-2) present in the ligand-binding domains (LBDs) of several NRs. The presence of an intact NR interaction module II in the NID is sufficient for both efficient interaction with NR holo-LBDs and stimulation of AF-2 activity. Modules I and III are poorly efficient on their own, but synergistically can promote interaction with NR holo-LBDs and AF-2 stimulation. TIF2 AD1 activity appears to be mediated through CBP, as AD1 could not be separated mutationally from the CBP interaction domain. In contrast, TIF2 AD2 activity apparently does not involve interaction with CBP. TIF2 exhibited the characteristics expected for a bona fide NR coactivator, in both mammalian and yeast cells. Moreover, in mammalian cells, a peptide encompassing the TIF2 NID inhibited the ligand-induced AF-2 activity of several NRs, indicating that NR AF-2 activity is either mediated ...Continue Reading

References

Jul 7, 1988·Nature·D MetzgerP Chambon
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·I G SchulmanR M Evans
Mar 11, 1995·Nucleic Acids Research·B Le DouarinR Losson
Feb 1, 1994·Protein Engineering·C Geourjon, G Deléage
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·G AllenbyP Chambon
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D M HeeryR Losson
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A BaniahmadB W O'Malley
Dec 15, 1995·Cell·D J MangelsdorfR M Evans
Dec 15, 1995·Cell·D J Mangelsdorf, R M Evans
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·H HongM R Stallcup
May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·S Yeh, C Chang
Sep 5, 1996·Nature·R Janknecht, T Hunter
Sep 5, 1996·Nature·D ChakravartiR M Evans
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·C L SmithB W O'Malley
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·T P YaoD M Livingston
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·B HansteinM Brown
Dec 19, 1996·Nature·A J Bannister, T Kouzarides
Apr 1, 1997·Current Opinion in Cell Biology·C K GlassM G Rosenfeld
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·P G WalfishM R Stallcup
Oct 1, 1996·Molecular Endocrinology·K B HorwitzL Tung

❮ Previous
Next ❯

Citations

May 29, 2000·Genes, Chromosomes & Cancer·M ChaffanetM J Pébusque
Aug 31, 2001·Journal of Cellular Biochemistry·S ChakrabortyG Nucifora
Mar 12, 2004·Biochemical Pharmacology·Franci A WeytsSylvia Christakos
Jun 21, 2005·The International Journal of Biochemistry & Cell Biology·Lucia AltucciHinrich Gronemeyer
Oct 17, 2002·Journal of Molecular Biology·Mark AllenMark Bycroft
Mar 27, 2001·Biochimica Et Biophysica Acta·S AraiJ Nishikawa
Jun 5, 1998·Trends in Genetics : TIG·R H GilesM H Breuning
Feb 13, 2003·Molecular and Cellular Endocrinology·Shiyou Chen, S Stoney Simons
Apr 23, 2003·Molecular and Cellular Endocrinology·T M TannerF Claessens
Nov 7, 1998·Molecular and Cellular Endocrinology·G Jenster
Mar 14, 2000·Gene·C Leo, J D Chen
Jun 26, 1998·Current Opinion in Cell Biology·J TorchiaM G Rosenfeld
Jun 26, 1998·Current Opinion in Cell Biology·D Moras, H Gronemeyer
Mar 11, 1999·Current Opinion in Genetics & Development·T Kouzarides
Mar 25, 2000·The Journal of Steroid Biochemistry and Molecular Biology·M NeedhamM Parker
Mar 26, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Lan LiaoJianming Xu
Aug 29, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Michael R StallcupDagang Chen
Oct 31, 2001·Trends in Cell Biology·B R Cairns
Jun 9, 2001·Trends in Endocrinology and Metabolism : TEM·K C Lee, W Lee Kraus
Jun 8, 2002·Molecular Genetics and Metabolism·Bin He, Elizabeth M Wilson
Dec 19, 2002·Cytokine & Growth Factor Reviews·Maofu FuRichard G Pestell
Sep 16, 1998·Current Opinion in Chemical Biology·M Resche-Rigon, H Gronemeyer
Oct 13, 2011·Chemical Reviews·Gregory S HarmonChristopher K Glass
Aug 25, 2009·Nature Reviews. Cancer·Jianming XuBert W O'Malley
Aug 18, 2000·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·S KatoJ Yanagisawa
May 8, 2010·The Journal of Biological Chemistry·Emily B AskewElizabeth M Wilson
Sep 15, 2012·The Journal of Biological Chemistry·Zhaoting WuLingyi Chen
Feb 8, 2006·The Journal of Biological Chemistry·David Y LeeMichael R Stallcup
Mar 30, 2010·Molecular & Cellular Proteomics : MCP·Ivan NalvarteJan-Ake Gustafsson
Apr 20, 2004·Assay and Drug Development Technologies·Taosheng ChenMartyn Banks
Apr 20, 2002·EMBO Reports·Ann BåvnerEckardt Treuter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.